IL‐1β reduces tonic contraction of mesenteric lymphatic muscle cells, with the involvement of cycloxygenase‐2 and prostaglandin E2

The lymphatic system maintains tissue homeostasis by unidirectional lymph flow, maintained by tonic and phasic contractions within subunits, ‘lymphangions’. Here we have studied the effects of the inflammatory cytokine IL‐1β on tonic contraction of rat mesenteric lymphatic muscle cells (RMLMC).

[1]  D. Zawieja,et al.  Colonic Insult Impairs Lymph Flow, Increases Cellular Content of the Lymph, Alters Local Lymphatic Microenvironment, and Leads to Sustained Inflammation in the Rat Ileum , 2015, Inflammatory bowel diseases.

[2]  F. Abreo,et al.  Downregulation of FoxC2 Increased Susceptibility to Experimental Colitis: Influence of Lymphatic Drainage Function? , 2015, Inflammatory bowel diseases.

[3]  O. Kaminuma,et al.  IL-17A induces hypo-contraction of intestinal smooth muscle via induction of iNOS in muscularis macrophages. , 2014, Journal of pharmacological sciences.

[4]  J. Alexander,et al.  Lymphatic dysregulation in intestinal inflammation: new insights into inflammatory bowel disease pathomechanisms. , 2014, Lymphology.

[5]  Markus F. Neurath,et al.  Cytokines in inflammatory bowel disease , 2014, Nature Reviews Immunology.

[6]  D. Zawieja,et al.  The effects of inflammatory cytokines on lymphatic endothelial barrier function , 2014, Angiogenesis.

[7]  ChatterjeeVictor,et al.  Mast cell-directed recruitment of MHC class II positive cells and eosinophils towards mesenteric lymphatic vessels in adulthood and elderly. , 2014 .

[8]  Stephen PH Alexander,et al.  The Concise Guide to Pharmacology 2013/14: G Protein-Coupled Receptors , 2013, British journal of pharmacology.

[9]  Adam J Pawson,et al.  The Concise Guide to Pharmacology 2013/14: Enzymes , 2013, British journal of pharmacology.

[10]  Adam J Pawson,et al.  The Concise Guide to Pharmacology 2013/14: Catalytic Receptors , 2013, British journal of pharmacology.

[11]  Joanna L. Sharman,et al.  The IUPHAR/BPS Guide to PHARMACOLOGY: an expert-driven knowledgebase of drug targets and their ligands , 2013, Nucleic Acids Res..

[12]  E. Sevick-Muraca,et al.  Cytokines are systemic effectors of lymphatic function in acute inflammation. , 2013, Cytokine.

[13]  E. Sevick-Muraca,et al.  Lymphatic Vascular Response to Acute Inflammation , 2013, PloS one.

[14]  D. Zawieja,et al.  An immunological fingerprint differentiates muscular lymphatics from arteries and veins. , 2013, Lymphatic research and biology.

[15]  P. von der Weid,et al.  Involvement of the NO-cGMP-K(ATP) channel pathway in the mesenteric lymphatic pump dysfunction observed in the guinea pig model of TNBS-induced ileitis. , 2013, American journal of physiology. Gastrointestinal and liver physiology.

[16]  S. Stacker,et al.  Vascular endothelial growth factor-D: signaling mechanisms, biology, and clinical relevance , 2012, Growth factors.

[17]  Jee In Kim,et al.  Reciprocal regulation controlling the expression of CPI-17, a specific inhibitor protein for the myosin light chain phosphatase in vascular smooth muscle cells. , 2012, American journal of physiology. Cell physiology.

[18]  G. Koh,et al.  Regulation and implications of inflammatory lymphangiogenesis. , 2012, Trends in immunology.

[19]  Kevin W Eliceiri,et al.  NIH Image to ImageJ: 25 years of image analysis , 2012, Nature Methods.

[20]  S. Stacker,et al.  VEGF-D promotes tumor metastasis by regulating prostaglandins produced by the collecting lymphatic endothelium. , 2012, Cancer cell.

[21]  K. Alitalo,et al.  The lymphatic vasculature in disease , 2011, Nature Medicine.

[22]  P. von der Weid,et al.  Role of the lymphatic system in the pathogenesis of Crohn's disease , 2011, Current opinion in gastroenterology.

[23]  S. Werner,et al.  An important role of lymphatic vessel activation in limiting acute inflammation. , 2011, Blood.

[24]  S. Danese.  Role of the vascular and lymphatic endothelium in the pathogenesis of inflammatory bowel disease: ‘brothers in arms’ , 2011, Gut.

[25]  D. Zawieja,et al.  Substance P Activates Both Contractile and Inflammatory Pathways in Lymphatics Through the Neurokinin Receptors NK1R and NK3R , 2011, Microcirculation.

[26]  P. von der Weid,et al.  Lymphatic pump function in the inflamed gut , 2010, Annals of the New York Academy of Sciences.

[27]  G. V. Chaitanya,et al.  Differential cytokine responses in human and mouse lymphatic endothelial cells to cytokines in vitro. , 2010, Lymphatic research and biology.

[28]  K. Alitalo,et al.  Stimulation of lymphangiogenesis via VEGFR-3 inhibits chronic skin inflammation , 2010, Journal of Experimental Medicine.

[29]  M. Muthuchamy,et al.  Regulatory mechanisms in lymphatic vessel contraction under normal and inflammatory conditions. , 2010, Pathophysiology : the official journal of the International Society for Pathophysiology.

[30]  C. Kilkenny,et al.  Guidelines for reporting experiments involving animals: the ARRIVE guidelines , 2010, British journal of pharmacology.

[31]  I. Cuthill,et al.  Animal Research: Reporting In Vivo Experiments: The ARRIVE Guidelines , 2010, British journal of pharmacology.

[32]  P. von der Weid,et al.  Characterization of biosynthesis and modes of action of prostaglandin E2 and prostacyclin in guinea pig mesenteric lymphatic vessels , 2009, British journal of pharmacology.

[33]  R. Khalil,et al.  Inflammatory cytokines in vascular dysfunction and vascular disease. , 2009, Biochemical pharmacology.

[34]  D. Ostanin,et al.  T cell transfer model of chronic colitis: concepts, considerations, and tricks of the trade. , 2009, American journal of physiology. Gastrointestinal and liver physiology.

[35]  M. Kuwano,et al.  Role of macrophages in inflammatory lymphangiogenesis: Enhanced production of vascular endothelial growth factor C and D through NF-kappaB activation. , 2008, Biochemical and biophysical research communications.

[36]  Y. Zhang,et al.  Contractility of placental vascular smooth muscle cells in response to stimuli produced by the placenta: roles of ACE vs. non-ACE and AT1 vs. AT2 in placental vessel cells. , 2008, Placenta.

[37]  Yushi Ito,et al.  Dual Modulation of Airway Smooth Muscle Contraction by Th2 Cytokines via Matrix Metalloproteinase-1 Production1 , 2008, The Journal of Immunology.

[38]  K. Murthy,et al.  Upregulation of RGS4 and downregulation of CPI-17 mediate inhibition of colonic muscle contraction by interleukin-1beta. , 2007, American journal of physiology. Cell physiology.

[39]  M. Grisham,et al.  Pathogenic angiogenesis in IBD and experimental colitis: new ideas and therapeutic avenues. , 2007, American journal of physiology. Gastrointestinal and liver physiology.

[40]  J. Colombel,et al.  The forgotten role of lymphangitis in Crohn’s disease , 2007, Gut.

[41]  Y. Iwakura,et al.  Intestinal inflammation downregulates smooth muscle CPI-17 through induction of TNF-alpha and causes motility disorders. , 2007, American journal of physiology. Gastrointestinal and liver physiology.

[42]  D. Jackson,et al.  An inflammation-induced mechanism for leukocyte transmigration across lymphatic vessel endothelium , 2006, The Journal of experimental medicine.

[43]  W. MacNaughton,et al.  Contractile activity of lymphatic vessels is altered in the TNBS model of guinea pig ileitis. , 2006, American journal of physiology. Gastrointestinal and liver physiology.

[44]  T. Kenakin,et al.  GW627368X ((N‐{2‐[4‐(4,9‐diethoxy‐1‐oxo‐1,3‐dihydro‐2H‐benzo[f]isoindol‐2‐yl)phenyl]acetyl} benzene sulphonamide): a novel, potent and selective prostanoid EP4 receptor antagonist , 2006, British journal of pharmacology.

[45]  W. Cao,et al.  Production of IL-1beta, hydrogen peroxide, and nitric oxide by colonic mucosa decreases sigmoid smooth muscle contractility in ulcerative colitis. , 2005, American journal of physiology. Cell physiology.

[46]  Guillermo Oliver,et al.  Lymphatic vascular defects promoted by Prox1 haploinsufficiency cause adult-onset obesity , 2005, Nature Genetics.

[47]  S. Collins,et al.  Mechanisms underlying the maintenance of muscle hypercontractility in a model of postinfective gut dysfunction. , 2005, Gastroenterology.

[48]  S. Collins,et al.  Interleukin-4- and -13-induced hypercontractility of human intestinal muscle cells-implication for motility changes in Crohn's disease. , 2005, American journal of physiology. Gastrointestinal and liver physiology.

[49]  D. Zawieja,et al.  Regional Variations of Contractile Activity in Isolated Rat Lymphatics , 2004, Microcirculation.

[50]  R. Breyer,et al.  Pharmacology and signaling of prostaglandin receptors: multiple roles in inflammation and immune modulation. , 2004, Pharmacology & therapeutics.

[51]  H. Miura,et al.  The vascular contribution in the pathogenesis of inflammatory bowel disease. , 2003, American journal of physiology. Heart and circulatory physiology.

[52]  David Zawieja,et al.  Molecular and functional analyses of the contractile apparatus in lymphatic muscle , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[53]  M. Büchler,et al.  Characterisation of Acute Murine Dextran Sodium Sulphate Colitis: Cytokine Profile and Dose Dependency , 2000, Digestion.

[54]  D. Beasley.  COX-2 and cytosolic PLA2mediate IL-1β-induced cAMP production in human vascular smooth muscle cells. , 1999, American journal of physiology. Heart and circulatory physiology.

[55]  K. Alitalo,et al.  Proinflammatory Cytokines Regulate Expression of the Lymphatic Endothelial Mitogen Vascular Endothelial Growth Factor-C* , 1998, The Journal of Biological Chemistry.

[56]  J. Maclouf,et al.  Cyclooxygenase-2 and synthesis of PGE2 in human bronchial smooth-muscle cells. , 1997, American journal of respiratory and critical care medicine.

[57]  M. Yacoub,et al.  Induction of cyclo‐oxygenase‐2 by cytokines in human cultured airway smooth muscle cells: novel inflammatory role of this cell type , 1997, British journal of pharmacology.

[58]  C. Benishin,et al.  Prostaglandin E2 contracts vascular smooth muscle and inhibits potassium currents in vascular smooth muscle cells of rat tail artery. , 1995, The Journal of pharmacology and experimental therapeutics.

[59]  Y. Xia,et al.  Cloning two isoforms of rat cyclooxygenase: differential regulation of their expression. , 1993, Archives of biochemistry and biophysics.

[60]  H. Granger,et al.  Distribution, propagation, and coordination of contractile activity in lymphatics. , 1993, The American journal of physiology.

[61]  C. Nast,et al.  Interleukin 1 (IL-1) gene expression, synthesis, and effect of specific IL-1 receptor blockade in rabbit immune complex colitis. , 1990, The Journal of clinical investigation.

[62]  H. Movat,et al.  Suppression of fluid pumping in isolated bovine mesenteric lymphatics by interleukin-1: interaction with prostaglandin E2. , 1989, Microvascular research.

[63]  A. F. Muller,et al.  Human recombinant interleukin-1 beta and -alpha, but not recombinant tumor necrosis factor alpha stimulate ACTH release from rat anterior pituitary cells in vitro in a prostaglandin E2 and cAMP independent manner. , 1988, Neuroendocrinology.

[64]  M. Johnston,et al.  Regulation of lymphatic contractility by arachidonate metabolites , 1981, Nature.

[65]  Ralph O. Smith.  Lymphatic contractility; a possible intrinsic mechanism of lymphatic vessels for the transport of lymph. , 1949 .

[66]  V. Chatterjee,et al.  Mast cell-directed recruitment of MHC class II positive cells and eosinophils towards mesenteric lymphatic vessels in adulthood and elderly. , 2014, Lymphatic research and biology.

[67]  I. Leodolter.  [Crohn's disease]. , 1967, Wiener Zeitschrift fur innere Medizin und ihre Grenzgebiete.

[68]  G PLACITELLI,et al.  [Ulcerative colitis]. , 1958, La Riforma medica.